Literature DB >> 27118749

Ocular presentation of natural killer/T-cell lymphoma in a Caucasian man.

Emily Hughes1, Helen Fogarty2, Anne Fortune2, David Keegan1.   

Abstract

Natural killer/T-cell (NK/T-cell) lymphoma-nasal subtype, is a rare form of non-Hodgkin's lymphoma, most common in South East Asia, and can have an ophthalmological presentation. This report describes a 51-year-old Caucasian man with uveitis, recurrent retinal detachment and paraneoplastic features subsequently diagnosed as NK/T-cell lymphoma. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 27118749      PMCID： PMC4854127          DOI： 10.1136/bcr-2016-215089

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  6 in total

1.  Epstein-Barr virus infected cells in the aqueous humour originated from nasal NK/T cell lymphoma.

Authors:  S Kase; K Namba; N Kitaichi; S Ohno
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

2.  Extranodal nasal-type natural killer/T-cell lymphoma masquerading as recalcitrant sinusitis.

Authors:  Young S Paik; Benjamin D Liess; Troy D Scheidt; Ellis A Ingram; Robert P Zitsch
Journal:  Head Neck       Date:  2010-02       Impact factor: 3.147

3.  Ocular-central nervous system lymphoma mimicking posterior scleritis with exudative retinal detachment.

Authors:  A P Hunyor; C A Harper; J O'Day; P A McKelvie
Journal:  Ophthalmology       Date:  2000-10       Impact factor: 12.079

4.  Vision-threatening complications of nasal T/NK lymphoma.

Authors:  Charmaine Hon; Alvin K H Kwok; Tony W H Shek; James C S Chim; Wing Y Au
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

5.  Peripheral T-cell lymphoma presenting as sclerouveitis.

Authors:  Thomas J Kirn; Norman B Levy; J J Benoit Gosselin; William J Rosen; Michael E Zegans
Journal:  Cornea       Date:  2007-10       Impact factor: 2.651

6.  Ocular involvement in nasal natural killer T-cell lymphoma.

Authors:  Luca Cimino; Chi-Chao Chan; DeFen Shen; Luciano Masini; Fiorella Ilariucci; Maurizio Masetti; Silvia Asioli; Antonio Sartori; Luca Cappuccini
Journal:  Int Ophthalmol       Date:  2008-04-26       Impact factor: 2.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.